Why the upcoming AGM votes matter RACGP members can make their voice heard on a number of important resolutions due to take place at the college’s annual general meeting.
In Practice: Last chance for early bird rates Discounted rates for next year’s International Medicine in Addiction conference are closing soon.
Second bivalent booster receives ATAGI recommendation The vaccine will become available in December and is recommended for people who have not had their first or second booster doses.
GPs say politics and money behind NSW pharmacy prescribing push The controversial move was announced a week after a new report showed pharmacy profits have soared on the back of increased service delivery.
RACGP issues thunderstorm asthma warning The college is urging the community to know the risks, signs, and appropriate steps to take as pollen levels rise.
RACGP Top End visit an ‘important step’ College leaders are travelling to remote parts of the NT this week ahead of next year’s transition to profession-led training.
Semaglutide unavailable in Australia until April 2023 GPs have been told not to initiate any new patients on either semaglutide or dulaglutide, which will also only have ‘limited availability’.
Vast majority of Australian population has had COVID: Seroprevalence survey Upwards of eight in 10 people have at some point likely contracted the disease, which is now the third leading cause of death nationwide.
Survey hints at increasing long COVID burden Half of the nearly 2200 people surveyed by Lung Foundation Australia reported ongoing symptoms more than four weeks after their initial infection.
New variants expected to supplant BA.5 in Australia Both XBB and BQ.1 possess a growth advantage over previous COVID strains, but there is no evidence to suggest either variant is more severe.